注:本产品仅用于科研,不可用于临床
Bortezomib抑制剂 生物活性
tezomib (ps - 341)是一个可逆的和有选择性的蛋白酶体抑制剂,20年代,强有力地抑制蛋白酶体(Ki = 0.6海里)通过瞄准一个threonine残基。Bortezomib干扰细胞周期、凋亡和抑制NF-κB。Bortezomib是Di一蛋白酶体抑制剂抗癌剂
Bortezomib抑制剂 IC50 & Target
Ki: 0.6 nM (20S proteasome)[1]
体外研究 (In Vitro) | Bortezomib (PS-341) (100 nM; 8 hours) results in the accumulation of cells in G2-M, with a corresponding decrease in the number of cells in G1[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Cycle Analysis[1]
| ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
体内研究 (In Vivo) | Bortezomib (PS-341) (0.3-1 mg/kg; i.v.; once weekly for 4 weeks) inhibits PC-3 Tumor Growth in Nude Mice[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||
分子量 | 384.24 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C19H25BN4O4 | ||||||||||||||||
CAS 号 | 179324-69-7 | ||||||||||||||||
中文名称 | |||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) | ||||||||||||||||
溶解性数据 | In Vitro: Ethanol : 66.67 mg/mL (173.51 mM; ultrasonic and warming and heat to 60°C) DMSO : 50 mg/mL (130.13 mM; Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|